Biotech & MedTech

Coeptis Therapeutics’ Dave Mehalick on Making Cell Therapy Universally Accessible

In a recent interview with InvestorNews, Dave Mehalick, Chairman, President, and CEO of Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP),…